Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003177005 | SCV003854428 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-02-28 | criteria provided, single submitter | clinical testing | The p.N767D variant (also known as c.2299A>G), located in coding exon 22 of the RB1 gene, results from an A to G substitution at nucleotide position 2299. The asparagine at codon 767 is replaced by aspartic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004009639 | SCV004829771 | uncertain significance | Retinoblastoma | 2023-08-15 | criteria provided, single submitter | clinical testing |